drugset / Trial / NCT01118741
Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)
NaSingle-groupOpen-labelTreatment
Summary
disulfiram is a DNA methyltransferase inhibitor that may provide benefit for patients with prostate cancer by restoring tumor suppressor genes.
Timeline
- Start
- 2010-05
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Disulfiram | Small molecule | 250 mg | Oral |
| Subject | Disulfiram | Small molecule | 500 mg | Oral |